Hirmand Mohammad
EVP & Chief Medical Officer at Turning Point Therapeutics, Inc.; Interim Chief Medical Officer at MEDIVATION, INC.
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Feb 9, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Turning Point Therapeutics, Inc.EVP & Chief Medical Officer
- MEDIVATION, INC.Interim Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Turning Point Therapeutics, Inc.10,969 shares
- MEDIVATION, INC.2,832 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MEDIVATION, INC.Plan not statedNov 9, 2015 2015
Sold 232 shares at $41.91 ($10k)
Hirmand Mohammad, Interim Chief Medical Officer
Sold 0.7% of holdings ($1.4M position)32,188 shares leftFirst sale on recordFiling
- 2 Form 4 sale MEDIVATION, INC.Plan not statedDec 3, 2015 +24 days
Sold 1,075 shares at $43.40 ($47k)
Hirmand Mohammad, Interim Chief Medical Officer
Sold 3.3% of holdings ($1.4M position)31,113 shares leftFiling
- 3 Form 4 sale MEDIVATION, INC.Plan not statedMar 4, 2016 +92 days
Sold 1,525 shares at $41.10 ($63k)
Hirmand Mohammad, Interim Chief Medical Officer
Sold 3.7% of holdings ($1.7M position)39,342 shares leftFiling
- 4 Form 4 sale Turning Point Therapeutics, Inc.UnusualJan 5, 2021 +1768 days
Sold 10,300 shares at $120.43 ($1.2M)
Hirmand Mohammad, EVP and Chief Medical Officer
Sold 97.3% of holdings ($1.3M position)284 shares leftFirst sale on recordFiling
- 5 Form 4 sale Turning Point Therapeutics, Inc.Plan not statedFeb 9, 2022 +400 days
Sold 669 shares at $36.30 ($24k)
Hirmand Mohammad, EVP & Chief Medical Officer
Sold 8.9% of holdings ($273k position)6,838 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2022 | Feb 11, 2022 | Turning Point Therapeutics, Inc. | EVP & Chief Medical Officer | Form 4 sale | 669 | $24k | 8.9% | Plan not stated | SEC |
| Jan 5, 2021 | Jan 5, 2021 | Turning Point Therapeutics, Inc. | EVP and Chief Medical Officer | Form 4 sale | 10,300 | $1.2M | 97.3% | Unusual | SEC |
| Mar 4, 2016 | Mar 7, 2016 | MEDIVATION, INC. | Interim Chief Medical Officer | Form 4 sale | 1,525 | $63k | 3.7% | Plan not stated | SEC |
| Dec 3, 2015 | Dec 4, 2015 | MEDIVATION, INC. | Interim Chief Medical Officer | Form 4 sale | 1,075 | $47k | 3.3% | Plan not stated | SEC |
| Nov 9, 2015 | Nov 12, 2015 | MEDIVATION, INC. | Interim Chief Medical Officer | Form 4 sale | 232 | $10k | 0.7% | Plan not stated | SEC |